Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Ichnos Sciences SA

Home Clinical Trial Sponsors and OrganizationsIchnos Sciences SA

Ichnos Sciences SA

ACTIVE

Chemin de la Combeta 5, La Chaux-De-Fonds, Neuchâtel, Switzerlandwww.glenmarkpharma.comSubsidiary

Part of Glenmark Pharmaceuticals Ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

13

2 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

10

76.9%

Phase 2

2

15.4%

Phase 1/2

1

7.7%

Trial Status Distribution

Active, not recruiting

1

7.7%

Completed

3

23.1%

Not yet recruiting

1

7.7%

Recruiting

4

30.8%

Terminated

3

23.1%

Unknown

1

7.7%

Clinical Trials

Trials sponsored by this organization (13)

A study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

Apr 202480 participants

A study to assess safety, tolerability, and anticancer activity of ISB 1442

Apr 2024121 participants

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

Nov 2023200 participants

Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma

Sep 202229 participants

A First-in-Human Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma

Not yet recruiting

Jun 2022121 participants

Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

Apr 20201 participant

A Study of GBR 830 in Adult Patients with Atopic Dermatitis

Active, not recruiting

Jul 2018468 participants

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

May 2018462 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials13
Approvals
News

Back to Organizations